from EURAZEO (EPA:RF)
EURAZEO SIGNS AN AGREEMENT TO SELL 100% OF PETERS SURGICAL’ SHARE CAPITAL TO ADVANCED MEDICAL SOLUTIONS GROUP PLC
EURAZEO SIGNS AN AGREEMENT TO SELL 100% OF PETERS SURGICAL’ SHARE
CAPITAL TO ADVANCED MEDICAL SOLUTIONS GROUP PLC
Paris, March 13, 2024
Eurazeo Small-mid buyout strategy and the management of Peters Surgical announce that they have signed an agreement to sell all the share capital of Peters Surgical to Advanced Medical Solutions Group plc (AIM: AMS), a world-leading specialist in tissue-healing technologies listed in the London Stock Exchange.
Eurazeo has been supporting Peters Surgical, a leading global provider of specialty surgical sutures, mechanical haemostasis and internal cyanoacrylate devices, as a majority shareholder, since 2013. Over the past years, Eurazeo has enabled the company to expand its presence in the operating room by developing organically and by acquiring new product ranges, such as haemostatic clips or surgical glue. Thanks to numerous acquisitions, Peters Surgical has also increased its shares of direct-selling capabilities, and expanded its geographical presence in the United States, in Asia and in key European countries (Germany, Poland, among others).
The transaction will allow Peters Surgical to benefit from significant complementarities with Advanced Medical Solutions Group plc in terms of portfolio of surgical products, of sales capabilities and commercial footprint in key territories as well as distribution networks.
 |  | ||
The transaction remains subject to approval of French authorities for foreign direct investment control. The sale of Peters Surgical would allow funds managed by Eurazeo, to receive estimated proceeds of €66m (of which c. €46m for Eurazeo’s Balance Sheet) upon closing. These proceeds are subject to adjustments based on completion accounts and earn-outs which could be triggered and paid in 2024 and 2025.
ABOUT EURAZEO
• Eurazeo is a leading global investment group, with a diversified portfolio of €35 billion in Assets Under Management, including €24 billion from third parties, invested in around 600 companies. With its considerable private equity, private debt, real estate asset and infrastructure expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its 400+ professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.
• Eurazeo has offices in Paris, New York, London, Frankfurt, Berlin, Milan, Madrid, Luxembourg, Shanghai, Seoul, Singapore and Sao Paulo.
• Eurazeo is listed on Euronext Paris.
• ISIN : FR0-00121121 - Bloomberg- : RF FP - Reuters : EURA.PA.
EURAZEO
1, rue Georges Berger – 75017 Paris www.eurazeo.com
Coralie Savin
GROUP CHIEF COMMUNICATIONS OFFICER csavin@eurazeo.com
+33 (0)6 86 89 57 48
Pierre Bernardin
HEAD OF INVESTOR RELATIONS pbernardin@eurazeo.com
+33 (0)1 44 15 16 76
David Sturken
H-ADVISORS MAITLAND
David.sturken@h-advisors.global
+44 (0) 7990 595 913
2 / 2